// App-Quantinova.ai

SUN-297 : FGFR2 Signaling Provides an Alternate Mode of Her2/Neu Activation in Breast Cancer

Researchers

Presenter

  • Wei Liu

Principal Investigators

  • Sylvia L. Asa

  • Shereen Z Ezzat

Medical Centers

  • Universtiy Health Network, Toronto, ON, Canada

  • Ontario Cancer Institute, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Epidermal growth factor receptor

  • Fibroblast growth factor receptor

  • Human epidermal growth factor receptor 2

  • Signal transducer and activator of transcription 3

Drug/Treatment

  • Trastuzumab

  • Lapatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved